Local family cord blood bank Cryoviva Singapore (https://cryoviva.com.sg) is continuing with its rapid geographic growth plans with an entry into…
Browsing: BioTech
Kintor Pharmaceutical Limited (Kintor Pharma, HKG: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced…
New Horizon Health (HKG:6606) (the Company), the first public listed cancer screening company in China, has today announced its financial…
New Drug Application for a potential First in Class GKA dorzagliatin accepted by NMPA Expansion of indications for dorzagliatin strengthened…
On June 10, 2021, the National Health Commission issued the notice “Distributing the Special Rectification Work Plan for Combating Illegal…
Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific…
China Biotech Services Holdings Limited (CH BIOTECH SER or Company, HKG:8037) is pleased to announce that Asia Molecular Diagnostic Laboratory…
An injection made of a hydrogel containing stem cells could treat damaged tissue following a heart attack. Heart muscle becomes…
BioMap, a biological computing platform enterprise, has recently completed the Series A funding round worth over a hundred million US…
Family cord blood bank Cryoviva Singapore is pleased to announce that it has made a successful foray into the UAE…
Sino Biopharmaceutical Limited (Sino Biopharmaceutical or the Company, together with its subsidiaries, the Group) (HKG:1177), a leading and innovation-driven pharmaceutical…
Magnetic field could boost blood vessel growth to regenerate damaged tissue. Magnetic field can be used to stimulate blood vessel…
Adlai Nortye Ltd. (hereinafter referred to as Adlai Nortye), a global biopharmaceutical company focused on developing innovative oncology drugs, today…
KG Information Systems Private Limited (KGISL), a global IT services, consulting, and business solution provider, today announced the acquisition of…
Offer Price Between HK$8.60 and HK$9.78 per Share To Raise Proceeds Up to HK$1,947 and 2,214 Million A leading player…
2021-6-23 / Gelonghui – China Biotech’s cell therapy was approved by the NMPA to enter Phase I clinical trials as…
Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced…
Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies and…
Amid rising concerns over the threat and economic impact of COVID-19, Holista Colltech Ltd (Holista) has been granted permission for…
China’s leading integrated online healthcare platform Dingdang Health announced today that it has raised US$220 million in its latest financing…